Clearside Biomedical (CLSD) Tops Q3 EPS by 1c

Clearside Biomedical (NASDAQ: CLSD) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $860 thousand versus the consensus estimate of $166.67 thousand.

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c